2 Top Pharma Stocks to Buy in June
Stocks are in a precarious place at the moment. Most U.S. companies are no longer trading on anything close to their underlying fundamentals, but rather on pure speculation about what may unfold over the next 12 to 24 months. While a viable COVID-19 vaccine, or perhaps a convalescent plasma therapy, could emerge in record time, there's also the chance that an effective pharmaceutical intervention may take years to develop. There's no way to know for sure -- a fact that simply isn't reflected in the hefty valuations of many U.S. stocks right now.
The point is that now is probably as good a time as ever to play it safe with your portfolio. And top pharma stocks -- especially those that pay a top-notch dividend -- are arguably one of the best ways to defend against uncertain times. Pharmaceutical companies, after all, generally sell a suite of life-saving products that are largely immune to economic downturns.
Image source: Getty Images.
Source Fool.com